Withanolide C Inhibits Proliferation of Breast Cancer Cells via Oxidative Stress-Mediated Apoptosis and DNA Damage
Some withanolides, particularly the family of steroidal lactones, show anticancer effects, but this is rarely reported for withanolide C (WHC)—especially anti-breast cancer effects. The subject of this study is to evaluate the ability of WHC to regulate the proliferation of breast cancer cells, using both time and concentration in treatment with WHC. In terms of ATP depletion, WHC induced more antiproliferation to three breast cancer cell lines, SKBR3, MCF7, and MDA-MB-231, than to normal breast M10 cell lines. SKBR3 and MCF7 cells showing higher sensitivity to WHC were used to explore the antiproliferation mechanism. Flow cytometric apoptosis analyses showed that subG1 phase and annexin V population were increased in breast cancer cells after WHC treatment. Western blotting showed that cleaved forms of the apoptotic proteins poly (ADP-ribose) polymerase (c-PARP) and cleaved caspase 3 (c-Cas 3) were increased in breast cancer cells. Flow cytometric oxidative stress analyses showed that WHC triggered reactive oxygen species (ROS) and mitochondrial superoxide (MitoSOX) production as well as glutathione depletion. In contrast, normal breast M10 cells showed lower levels of ROS and annexin V expression than breast cancer cells. Flow cytometric DNA damage analyses showed that WHC triggered γH2AX and 8-oxo-2′-deoxyguanosine (8-oxodG) expression in breast cancer cells. Moreover, <i<N</i<-acetylcysteine (NAC) pretreatment reverted oxidative stress-mediated ATP depletion, apoptosis, and DNA damage. Therefore, WHC kills breast cancer cells depending on oxidative stress-associated mechanisms..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Antioxidants - 9(2020), 9, p 873 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tzu-Jung Yu [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Apoptosis |
|---|
| doi: |
10.3390/antiox9090873 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ002705206 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ002705206 | ||
| 003 | DE-627 | ||
| 005 | 20240412213508.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antiox9090873 |2 doi | |
| 035 | |a (DE-627)DOAJ002705206 | ||
| 035 | |a (DE-599)DOAJ7c84e36e3c1d4cba97ffa6b3d32240f8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RM1-950 | |
| 100 | 0 | |a Tzu-Jung Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Withanolide C Inhibits Proliferation of Breast Cancer Cells via Oxidative Stress-Mediated Apoptosis and DNA Damage |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Some withanolides, particularly the family of steroidal lactones, show anticancer effects, but this is rarely reported for withanolide C (WHC)—especially anti-breast cancer effects. The subject of this study is to evaluate the ability of WHC to regulate the proliferation of breast cancer cells, using both time and concentration in treatment with WHC. In terms of ATP depletion, WHC induced more antiproliferation to three breast cancer cell lines, SKBR3, MCF7, and MDA-MB-231, than to normal breast M10 cell lines. SKBR3 and MCF7 cells showing higher sensitivity to WHC were used to explore the antiproliferation mechanism. Flow cytometric apoptosis analyses showed that subG1 phase and annexin V population were increased in breast cancer cells after WHC treatment. Western blotting showed that cleaved forms of the apoptotic proteins poly (ADP-ribose) polymerase (c-PARP) and cleaved caspase 3 (c-Cas 3) were increased in breast cancer cells. Flow cytometric oxidative stress analyses showed that WHC triggered reactive oxygen species (ROS) and mitochondrial superoxide (MitoSOX) production as well as glutathione depletion. In contrast, normal breast M10 cells showed lower levels of ROS and annexin V expression than breast cancer cells. Flow cytometric DNA damage analyses showed that WHC triggered γH2AX and 8-oxo-2′-deoxyguanosine (8-oxodG) expression in breast cancer cells. Moreover, <i<N</i<-acetylcysteine (NAC) pretreatment reverted oxidative stress-mediated ATP depletion, apoptosis, and DNA damage. Therefore, WHC kills breast cancer cells depending on oxidative stress-associated mechanisms. | ||
| 650 | 4 | |a withanolide | |
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a apoptosis | |
| 650 | 4 | |a oxidative stress | |
| 650 | 4 | |a DNA damage | |
| 653 | 0 | |a Therapeutics. Pharmacology | |
| 700 | 0 | |a Jen-Yang Tang |e verfasserin |4 aut | |
| 700 | 0 | |a Li-Ching Lin |e verfasserin |4 aut | |
| 700 | 0 | |a Wan-Ju Lien |e verfasserin |4 aut | |
| 700 | 0 | |a Yuan-Bin Cheng |e verfasserin |4 aut | |
| 700 | 0 | |a Fang-Rong Chang |e verfasserin |4 aut | |
| 700 | 0 | |a Fu Ou-Yang |e verfasserin |4 aut | |
| 700 | 0 | |a Hsueh-Wei Chang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Antioxidants |d MDPI AG, 2013 |g 9(2020), 9, p 873 |w (DE-627)DOAJ000099481 |x 20763921 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g number:9, p 873 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/antiox9090873 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/7c84e36e3c1d4cba97ffa6b3d32240f8 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2076-3921/9/9/873 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2076-3921 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |e 9, p 873 | ||